Putting a bit of lick and polish on the old wagon to roll it out to anyone who wants to provide some ongoing funding. Any player(s) getting involved at these levels will make a motsa as soon as that CE Mark is granted. Smart of them to detail the acqusition activity and premiums in this space. One of the things they missed (correct me if I'm wrong) is the the continuing revenue/rebate flow from R&D i.e. the longer they continue the trials, the longer that flow continues...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.16 |
Change
-0.010(0.86%) |
Mkt cap ! $21.74M | |||
| Open | High | Low | Value | Volume |
| $1.17 | $1.17 | $1.14 | $80.47K | 69.48K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 2150 | $1.16 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.17 | 7380 | 1 |
View Market Depth
| Last trade - 16.10pm 25/07/2025 (20 minute delay) ? |
| OSL (ASX) Chart |